Connect with us

Health Studies

Microwave Ablation Market to Reflect Steady Growth Rate by 2023

Published

on

Press Release

Overview:

Microwave ablation refers to the surgical removal of a body tissue by transferring heat to the target tissue. The process is used to remove a tiny or large quantity of tissue. A specially equipped needle is inserted near the site with image-guided modalities such as computed tomography, ultrasonography, and magnetic resonance imaging. The needle is subjected to various form of electrical tests depending on the type of technology used. This is a form of thermal ablation with energy spectrum of 300 MHz to 300 GHz used to produce tissue-heating effects. The increasing demand for energy-based ablation devices has increased the demand for microwave ablation procedures across the globe. The market is driven by several factors that contribute to the business growth globally.

The rise in awareness about minimally invasive surgeries or procedures has created a high adoption as it is less painful, performed as an outpatient procedure, and unlike traditional open surgeries they are less expensive. Minimally invasive surgeries are emerging as potential replacements for conventional therapeutic cancer surgeries for the treatment of various tumors of the prostate gland, lungs, and liver. Further, robotic navigation technologies that perform microwave ablation procedures more accurately are being incorporated to increase the popularity of these surgeries. The cost of microwave tissue ablation treatment is directly proportional to the size of the tissue/tumor and the number of probes required for the surgery.

Request for Report sample:  https://www.trendsmarketresearch.com/report/sample/9885

The major products in the market include:

  • Solero MTA System
  • NEUWAVE Microwave Ablation System
  • Evident MW Ablation System
  • AveCure Microwave System
  • MicroThermX Devices

The market is dominated by Medtronic, AngioDynamics, NeuWave Medical (now Johnson & Johnson), MedWaves, and Perseon which has more than 75% market share in the Global Microwave Ablation Devices market. Factors, such as the increased prevalence of chronic disorders, growing popularity about minimally invasive surgeries, focus on early prevention, and the increase in disposable income, are driving the market growth.

Market Analysis:

The Global Microwave Ablation Devices Market is estimated to witness a CAGR of 14.8% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product type, end-users, and regions.

Regional Analysis:

The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the microwave ablation devices market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the number of microwave ablation procedures due to the rise in disposable income, presence of a large pool of chronic patient population, and focus toward healthcare infrastructure. However, the high cost of devices and expensive procedural cost, lack of skilled electrophysiologist, lack of proper reimbursement policies, lack of awareness about advanced ablation devices in developing countries have a significant impact on the overall market growth.

Request for Report Discount: https://www.trendsmarketresearch.com/report/discount/9885

Product Analysis:

Consumables are the fastest growing segment and dominates the global ablation market with 65% of the total market. Cardiac arrhythmias are the most popular ablation treatment followed by cancer ablation methods in all the ablation types. The increase in the prevalence of chronic disorders and growing number of microwave ablation procedures are expected to drive the consumables market during the forecast period. The generator/electrosurgical unit segment is growing at a steady growth rate and is expected to see a significant growth in the emerging markets.

Key Players:

Medtronic, AngioDynamics, NeuWave Medical (now Johnson & Johnson), MedWaves, Perseon, and other predominate & niche players.

Competitive Analysis:

The Global Microwave Ablation Devices market is growing faster and has immense growth opportunities for vendors, especially in the developed regions. The presence of large, small, and local vendors in the market possess high competition. The vendors have a strong focus on acquiring smaller companies and expanding their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&A. They form strategic alliances for the marketing or manufacturing of microwave ablation devices.

Benefits:

The report provides complete details about the usage and adoption rate of microwave ablation devices for the treatment of various chronic disorders. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the ablation devices adoption in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.

Full View of Report Description: https://www.trendsmarketresearch.com/report/analysis/IR/global-microwave-ablation-market

View More:Healthcare, Pharmaceuticals & Medical Devices

This post was originally published on Health News Office

General Health

Nurse Call Systems Market will Likely Rise to US$2,665.98 Million by 2025

Published

on

Press Release

Advanced medical need enhances the demand for nurse call system across the world, which in turn drives the global nurse call systems market. Investment in healthcare needs by patients and their immediate families provides a grip over the nurse call systems market. The global nurse call systems market is likely to expand at a CAGR of 10.9% during the forecast period 2018 to 2026. Also, it is expected to reach an estimated valuation of US$2, 665.98 mn by the end of forecast period.

In terms of Geography, North America is expected to dominate the global nurse system market due to its rising geriatric population in the region. Simultaneously, Asia Pacific is expected to register a higher growth in the region due to increased demand for safe and secure wired nurse call solutions. Nurse call systems market is segmented in to intercoms, audio/video system, digital, mobile system, and IP system. However, IP system is expected to register a highest growth during the forecast period.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2173

Rising Demand of Diseases to Bolster Demand

Rising number of diseases paralysis, immobility due to surgeries, and other acute diseases creates a demand for nurse call system. Rise in disposable income and health care expenses drives the global nurse system market to strengthen during the forecast period. Additionally, geriatric population and availability of medical insurance to cover the expenses pushes the global nurse call systems market.

Moreover, wireless connectivity in communication is growing at a rapid rate. Improved and innovative technology also acts as a catalyst in the expansion of the global nurse call systems market. With the availability of advanced technology, improved products such as inter connecting nurse call system with mobile phones and nurse station in the hospitals contributes to the expansion of nurse call systems market. Thus, the global nurse call systems market is expected to witness a staggering growth during the forecast period.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2173

Hospitals & Old age Homes to Strengthen Market

Large demand comes from multi-specialty hospitals due to rising number of patients seeking in house treatments. This calls for integration of sophisticated solutions keeping patient’s need and care into consideration. Rising number of emergency cases also fuels the market for nurse call systems. Due to rise in the number of aging population, there’s a high demand for old age homes or assisted living to cater to their medical needs. Off late, the number of old age homes or assisted living care providers are increasing This creates an increased demand for the nurse call system pushing the global nurse call systems market to stellar growth during the forecast period.

A Transparency Market Research (TMR) report elucidates on competitive market in the global nurse call market. Some prominent players in the market are Azure Healthcare Ltd., Ascom Holding AG, Jeron Electronic System, Inc., Hill –Rom Holdings, Inc., and Tek Tone Sound & Signal Mfg., Inc. The global nurse call systems market is highly competitive. These companies are under cut throat competition and in a race to outdo each other. They are adopting different strategies to introduce improved products at a better price. They are expected entire into partnerships and acquisition to enhance their position the global market. These companies are investing in technology for innovative products to gain over the competitive edge in the global nurse call system.

This post was originally published on Health News Office

Continue Reading

General Health

Anticoagulants Market to Occur at a Promising 8.0% CAGR During 2018-2026

Published

on

Press Release

the global anticoagulants market is expected to touch US$ 40,158.4 mn by the end of the forecast period. The market was valued US$ 21,759.3 mn in 2018. The growth of the market is anticipated to occur at a promising 8.0% CAGR during 2018-2026.

From the perspective of drug class, factor Xa inhibitors segment is gaining traction in the global anticoagulants market due to its high usage in various indications such as stroke, heart attack, pulmonary embolism (PE), angina, surgery, and deep venous thrombosis (DVT). On the regional front, North America showcases the highest share in the global anticoagulants market with growing number of several surgical procedures such as knee and hip replacements, and rising healthcare expenditures.

Rapid Introduction of Innovative Oral Anticoagulants Drugs Fillip Market

Anticoagulants drugs are the chemical substances which prevent blood coagulation and prolong blood clotting time. Such drugs are primarily used for reducing the risks associated with blood clots in several medical conditions. Therefore, growth of the global anticoagulants market is majorly fueled by the rising prevalence of cardiovascular diseases and venous thromboembolism (VTE). Along with this, rapid adoption of novel oral anticoagulants (NOACs) and growing awareness about NOACs to reduce risks of chronic diseases in the developing regions are also providing impetus to the growth of the global anticoagulants market.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60924

Furthermore, surging demand of novel therapeutics and higher unmet medical needs in both developing and developed economies are also supporting growth in the global anticoagulants market. Apart from these, other major factors such as increasing number of people with obesity, rising elderly population, and flourishing healthcare industry worldwide are also propelling expansion in the global anticoagulants market. However, rising investments in research and development in the pharmaceutical sector and growing cases of hip and knee replacement surgeries are also contributing to an increasing demand in the global anticoagulants market.

Risk of Drugs’ Side-effects to Obstruct Market Growth

Although, the global anticoagulants market is growing steadily due to the numerous advantages it provides to the patients, however, it still faces some challenges which hamper its growth. Stringent rules and regulations set by several governments and risk of complications and side-effects associated with consuming oral anticoagulants are a couple of these roadblocks. Nonetheless, technological advancements in diagnosis of deep vein thrombosis (DVT) and rising incidences of DVT are believed to overcome these obstructions in the coming years.

The global anticoagulants market depicts a highly fragmented vendor landscape, observes Transparency Market Research (TMR). Different scales of players in the market are competing among themselves to achieve the top spot. Other than the players, several companies in the global anticoagulants market are also vying for a permanent position.

The topmost companies in the global anticoagulants market are emphasizing on delivering the most effective drugs. Their mission is to develop, discover, and deliver innovative medicines which help patients prevail over serious illnesses and diseases. Therefore, these companies are heavily investing in research and development to invent specific drugs with great potential. Moreover, through the research and development organization, such companies are trying to build a sustainable pipeline of several potential therapies. They are partnering with other large vendors in the global anticoagulants market to broaden their geographical territories and accelerate their research work. A few renowned companies’ names in the global anticoagulants market include Bristol-Myers Squibb Company, Johnson & Johnson Services, Daiichi Sankyo, Bayer Healthcare, and Sanofi.

This post was originally published on Health News Office

Continue Reading

General Health

Urinalysis Market to Reach an Estimated Value of US$1.5 Billion by 2024

Published

on

Press Release

the global urinalysis market to attain a valuation of US$1.5 bn by 2024-end. Experts further project that the growth of the market is expected to occur at a promising 5.4% CAGR during the assessment period from 2016-2024.

Among several test settings, the laboratory based segment is emerging as the leading shareholder in the global urinalysis market. Along with mushrooming private healthcare facilities in both developed and developing economies, the demand for private laboratories is also rising. Region wise, Asia Pacific is predicted to dominate in the global urinalysis market with the increasing focus on healthcare in countries like China and India.

Growing Prevalence of Kidney Diseases Worldwide to Boost Market

Urinalysis is a type of test which is mainly conducted to analyze urine samples. This test assists detection of a wide array of disorders include kidney diseases, diabetes, and urinary tract infection. Urinalysis is basically carried out as pre-surgery preparation, and forms of a part of routine medical check-up in hospitals, upon admission of patients afflicted with disorders. Moreover, it helps in identifying the cause of various symptoms such as abdominal pain and painful urination. Such facilities are majorly fueling growth in the global urinalysis market. Along with these, increasing prevalence of several types of kidney diseases and rapid implementation of PPACA are also providing impetus to the growth of the global urinalysis market.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Furthermore, the urinalysis needs various products during the test which include urine analyzer, dipstick, POC, and reagent. However, the two key product types are consumables and instruments. Rising incidences of chronic diseases due to the rapid change in lifestyle as well as environment has resulted in the need for advanced tests. Such factors are also propelling expansion in the global urinalysis market. However, another factor majorly fueling demand in the global urinalysis market include increasing number of surgeries and rising awareness about healthcare to receive treatment at early stages.

High Cost of Tests May Deter Market’s Growth 

While there are numerous factors supporting the growth of the global urinalysis market, a few challenges exist as major market restraints. High cost of tests and equipment are a couple of these restraining factors. Such expenses make it difficult for economically unstable people to afford the test procedures. Nonetheless, rising governments’ supports and availability of several health insurances are believed to underpin the growth momentum in the global urinalysis market.

This post was originally published on Health News Office

Continue Reading

Trending